|
Volumn 10, Issue 2, 2012, Pages 134-136
|
Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-hodgkin lymphoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
HEMOGLOBIN;
IBRITUMOMAB TIUXETAN;
PREDNISONE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RITUXIMAB;
VINCRISTINE;
ADULT;
ANEMIA;
ARTICLE;
BLOOD SMEAR;
BLOOD TRANSFUSION;
BONE MARROW BIOPSY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GRADING;
CASE REPORT;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FEVER;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HUMAN TISSUE;
LARGE CELL LYMPHOMA;
LEUKOCYTE COUNT;
LUNG NODULE;
LYMPH NODE BIOPSY;
LYMPHADENOPATHY;
LYMPHOCYTE COUNT;
NEUTROPHIL COUNT;
NIGHT SWEAT;
NONHODGKIN LYMPHOMA;
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;
POSITRON EMISSION TOMOGRAPHY;
RADIOIMMUNOTHERAPY;
REMISSION;
THROMBOCYTE COUNT;
TREATMENT RESPONSE;
WEIGHT REDUCTION;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
HEMOGLOBINURIA, PAROXYSMAL;
HUMANS;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
MIDDLE AGED;
PREDNISONE;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 84857066370
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (7)
|